SCHEMBL4465130

SCHEMBL4465130

N#CC1(Nc2ccc(I)cc2)CCN(C(=O)O)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.40
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA4 P22748 3/20 0.39
CA5A P35218 3/20 0.39
CA7 P43166 3/20 0.39
CA9 Q16790 3/20 0.39
CA13 Q8N1Q1 3/20 0.39
CA14 Q9ULX7 3/20 0.39
OPRM1 P35372 1/20 0.35
FPR2 P25090 3/20 0.33
FAAH O00519 1/20 0.33
CTSB P07858 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
EPHX2 P34913 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761108 0.81 PTPN2 (0.43) NPC1ALDH1A1RAB9A
SCHEMBL4464960 0.80 SMN1; SMN2 (0.37) CYP1A2SMN1; SMN2GAACA12CA1
SCHEMBL14916885 0.77 CYP1A2 (0.49) CYP1A2SMN1; SMN2GAACA12CA1
SCHEMBL3409415 0.77 CYP1A2 (0.73) CYP1A2SMN1; SMN2GAAOPRM1ALDH1A1
SCHEMBL755767 0.76 SMN1; SMN2 (0.34) CYP1A2SMN1; SMN2GAACA12CA1
SCHEMBL193707 0.76 CYP1A2 (0.71) CYP1A2SMN1; SMN2GAAALDH1A1
SCHEMBL16876699 0.75 SMN1; SMN2 (0.63) CYP1A2SMN1; SMN2CA12CA1CA2
SCHEMBL17149495 0.74 CYP1A2 (0.44) CYP1A2SMN1; SMN2GAACA12CA1
SCHEMBL21383795 0.73 SMN1; SMN2 (0.41) SMN1; SMN2CA12CA1CA2CA4
SCHEMBL7018431 0.71 CTSS (0.36) CTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073635-A1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-07-01 EP disclosed
WO-2008045250-A1 MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-04-17 WO disclosed